Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025
Mar 06, 2026
Mumbai (Maharashtra) [India], March 6: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its recognition among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA). Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally, and the leader across all sectors in India, surpassing both Indian and international peers.
Read More...
